WAFERGEN BIO-SYSTEMS, INC.

Profile

Company Names

WAFERGEN BIO-SYSTEMS, INC.

Addresses

7400 PASEO PADRE PARKWAY, FREMONT, CA 94555

BAYSIDE TECHNOLOGY CENTER, 46531 FREMONT BLVD., FREMONT, CA 94538

Phone Numbers

(510) 651-4450

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

NEVADA

Total Amount Raised:

$55,565,250.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-08-27 
$13,668,500.00 
$15,000,000.00 
$1,331,500.00 
Equity 
3
2011-05-25 
$30,550,000.00 
$30,550,000.00 
$0.00 
Equity, Debt 
2
2009-11-11 
$5,085,500.00 
$5,085,500.00 
$0.00 
Equity 
1
2009-05-28 
$6,261,250.00 
$6,261,250.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MONA 
 
CHADHA 
EXECUTIVE OFFICER
WAFERGEN BIO-SYSTEMS, INC.   |  NEURAVA INC.
ROBERT 
 
CORADINI 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.   |  TRINITY MEDICAL DEVICES INC.
SCOTT 
 
DAVIDSON 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.   |  RAIT-MELODY 2016 HOLDINGS TRUST   |  TEXAS HEALTH SURGERY CENTER ALLIANCE, LLC   |  RAIT-MELODY 2017 HOLDINGS TRUST   |  REVOLV GLOBAL INC
ROBERT 
J. 
HARIRI 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.   |  ATLAS THERAPEUTICS CORP   |  MYOS CORP   |  PROVISTA DIAGNOSTICS INC.   |  CELULARITY INC
JOHN 
 
HARLAND 
EXECUTIVE OFFICER
WAFERGEN BIO-SYSTEMS, INC.
R. 
DEAN 
HAUTAMAKI 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.
RAYMOND 
DEAN 
HAUTAMAKI 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.
DONALD 
 
HUFFMAN 
EXECUTIVE OFFICER
WAFERGEN BIO-SYSTEMS, INC.   |  AMARANTUS BIOSCIENCE HOLDINGS, INC.   |  STEADYMED LTD.
MAKOTO 
 
KANESHIRO 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.
JOEL 
 
KANTER 
DIRECTOR
FIRST WAVE TECHNOLOGIES, INC.   |  DR. TATTOFF, INC.   |  MEDISYNC BIOSERVICES INC   |  WAFERGEN BIO-SYSTEMS, INC.   |  VYTERIS, INC.   |  FIRST WAVE PRODUCTS GROUP, LLC   |  MERCATOR MEDSYSTEMS INC   |  20/20 GENESYSTEMS, INC.   |  CVR MEDICAL CORP.   |  MEDITE CANCER DIAGNOSTICS, INC.   |  APPLIED UV, INC.
JOSEPH 
 
PESCE 
DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.
ALNOOR 
 
SHIVJI 
DIRECTOR, EXECUTIVE OFFICER
WAFERGEN BIO-SYSTEMS, INC.   |  INVOLVER, INC.
TIMOTHY 
 
TRICHE 
DIRECTOR
NOVELIX PHARMACEUTICALS INC   |  WAFERGEN BIO-SYSTEMS, INC.   |  GENOMEDX BIOSCIENCES INC.   |  CELSEE, INC.
IVAN 
 
TRIFUNOVICH 
EXECUTIVE OFFICER, DIRECTOR
WAFERGEN BIO-SYSTEMS, INC.   |  DREN BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-10
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2013-08-27 
2011-06-01
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-05-25 
2010-02-24
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2009-11-11 
2009-09-15
D/A
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2009-05-28 
2009-07-06
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
$1 - $1,000,000 
Equity 
2009-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NATIONAL SECURITIES CORPORATION
7569
NONE
NONE
OPPENHEIMER + CO. INC.
249
NONE
NONE
SUMMER STREET RESEARCH PARTNERS
127142
NONE
NONE
MADISON WILLIAMS AND COMPANY
149530
NONE
NONE
GILFORD SECURITIES INCORPORATED
8076
NONE
NONE
SPENCER TRASK VENTURES, INC.
28373
NONE
NONE
NEWPORT COAST SECURITIES, INC.
16944
SPENCER TRASK VENTURES, INC.
28373
SPENCER TRASK VENTURES, INC.
28373